Coding sequence mutations and promoter and intron nucleotide polymorphisms related to the human ABCA7 locus have been associated with an increased risk for AD, promoting and highlighting ABCA7 as a new significant risk marker besides APOE4 [188,189,192,193,194,195]. This evidence concerns the gene ABCA7 and Alzheimer disease.